Chief Scientific Officer · OnKure Therapeutics, Inc. · OnKure Therapeutics, Inc. — Employee Stock Option (right to buy)
Side
A
Value
—
Shares
50.0K
Price
—
Executed
Aug 7, 2026
Disclosed
Aug 11, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Aug 7 executedAug 11, 2026 disclosed
OKUR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
OnKure Therapeutics, Inc. — Employee Stock Option (right to buy)
Ticker
OKUR
Shares
50.0K
Price per share
$0
Execution date (reported)
Aug 7, 2026
Owned after transaction
50.0K shares
Days from execution to publication
4
What this establishes
Hartley Dylan filed this Form 4 reporting a grant or award of OKUR on Aug 7, 2026. It became public on Aug 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Hartley Dylancik:0002037442
Issuer
OnKure Therapeutics, Inc.cik:0001637715
Revision history · 0
No field has changed since this record was first ingested.
